Philippe Bougnoux

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Javier Cortés, Joyce O’Shaughnessy, David Loesch et al. · The Lancet · 2011 · 1.1K citations

Metastatic Breast Cancer, Oncology, Breast Oncology +8

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

N‐3 and N‐6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case‐control study in Tours, France

Virginie Maillard, Philippe Bougnoux, Pietro Ferrari et al. · International Journal of Cancer · 2001 · 265 citations · Full text

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

Philippe Bougnoux, Nawale Hajjaji, M N Ferrasson et al. · British Journal of Cancer · 2009 · 257 citations · Full text

Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells

Ludovic Gillet, Sébastien Roger, Pierre Besson et al. · Journal of Biological Chemistry · 2009 · 201 citations · Full text

Cancer Biology, Cellular Physiology, Tumor Biology +23